America[美国药品]
|
Cefotetan |
CefotetanforInjection
Rxonly
ForIntravenousUseOnly
Toreducethedevelopmentofdrug-resistantbacteriaandmaintaintheeffectivenessofcefotetanandotherantibacterialdrugs,cefotetanshouldbeuse.. |
录入者:admin 发表于:2014-11-09
查阅全文... |
Elaprase |
ELAPRASEâ„¢(idursulfase)
Solutionforintravenousinfusion
Riskofanaphylaxis.
Life-threateninganaphylacticreactionshavebeenobservedinsomepatientsduringELAPRASEinfusions.. |
录入者:admin 发表于:2014-11-08
查阅全文... |
Belsomra(Suvorexant)Tablets |
HIGHLIGHTSOFPRESCRIBINGINFORMATION
ThesehighlightsdonotincludealltheinformationneededtouseBELSOMRAsafelyandeffectively.SeefullprescribinginformationforBELSOMRA.
BELSOMRA®(suvorexant)tablets,f.. |
录入者:admin 发表于:2014-11-07
查阅全文... |
Xolair |
ThesehighlightsdonotincludealltheinformationneededtouseXolairsafelyandeffectively.SeefullprescribinginformationforXolair.InitialU.S.Approval:2003
Anaphylaxispresentingasbronchospasm,hypotens.. |
录入者:admin 发表于:2014-11-07
查阅全文... |
Simponi |
ThesehighlightsdonotincludealltheinformationneededtouseSIMPONI(golimumab)safelyandeffectively.SeefullprescribinginformationforSIMPONI.SIMPONI(golimumab)Injection,solutionforsubcutaneoususeInitia.. |
录入者:admin 发表于:2014-11-06
查阅全文... |
SIMPONI |
GenericNameandFormulations:
Golimumab50mg/0.5mL,100mg/mL;solnforSCinj;preservative-free.
Company:
JanssenBiotech,Inc.
IndicationsforSIMPONI:
Moderately-to-severelyactiverheumatoidarthr.. |
录入者:admin 发表于:2014-11-06
查阅全文... |
Kabiven |
LabelandApprovalHistory
DrugName(s)KABIVENANDPERIKABIVEN
FDAApplicationNo.(NDA)200656
ActiveIngredient(s)AMINOACIDS;ELECTROLYTES;DEXTROSE;LIPID
CompanyFRESENIUSKABI
Action
.. |
录入者:admin 发表于:2014-11-03
查阅全文... |
|